Pittenger & Anderson’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Pittenger & Anderson's TGTX Position: Q3 2026 in Review
Pittenger & Anderson held its TG Therapeutics (TGTX) position steady in Q3 2026 at 612 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #340.
Pittenger & Anderson first reported a position in TGTX in Q3 2025 and has held it in 5 quarters since. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Pittenger & Anderson held 612 shares of TG Therapeutics worth $34.1K as of Q3 2026.
- Pittenger & Anderson left its TG Therapeutics share count unchanged in Q3 2026.
- TG Therapeutics made up ﹤0.01% of Pittenger & Anderson's portfolio in Q3 2026, its #340 holding.
- Pittenger & Anderson first reported a position in TG Therapeutics in Q3 2025 and has held it in 5 quarters since.
- 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Pittenger & Anderson's 13F filing for Q3 2026, filed 2 Nov 2026.